ClinicalTrials.gov record
Active, not recruiting Phase 3 Interventional Results available

A Study of Abemaciclib (LY2835219) in Participants With Previously Treated KRAS Mutated Lung Cancer

ClinicalTrials.gov ID: NCT02152631

Public ClinicalTrials.gov record NCT02152631. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Apr 23, 2026, 5:55 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

JUNIPER: A Randomized Phase 3 Study of Abemaciclib Plus Best Supportive Care Versus Erlotinib Plus Best Supportive Care in Patients With Stage IV NSCLC With a Detectable KRAS Mutation Who Have Progressed After Platinum-Based Chemotherapy

Study identification

NCT ID
NCT02152631
Recruitment status
Active, not recruiting
Study type
Interventional
Phase
Phase 3
Lead sponsor
Eli Lilly and Company
Industry
Enrollment
453 participants

Conditions and interventions

Interventions

  • Abemaciclib Drug
  • Erlotinib Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Oct 2, 2014
Primary completion
Sep 14, 2017
Completion
Nov 30, 2026
Last update posted
Feb 5, 2026

2014 – 2026

United States locations

U.S. sites
54
U.S. states
29
U.S. cities
42
Facility City State ZIP Site status
Highlands Oncology Group Fayetteville Arkansas 72703
St. Bernards Medical Center Jonesboro Arkansas 72401
City of Hope National Medical Center Duarte California 91010
University of California - San Diego La Jolla California 92037
Loma Linda University School of Medicine Loma Linda California 92350
CBCC Global Research, Inc. Los Angeles California 90024
Central Coast Medical Oncology Corporation Los Angeles California 90024
Fort Wayne Oncology & Hematology Los Angeles California 90024
SMO TRIO -Translational Research Los Angeles California 90024
St. Joseph Heritage Medical Group Los Angeles California 90024
UCLA Department of Medicine-Hematology/Oncology Los Angeles California 90024
Cancer Care Associates Medical Group Los Angeles California 90095
Dignity Health Care Institute Sacramento California 95816
Alegent Immanuel Cancer Center Englewood Colorado 80112
Jewish Hospital Englewood Colorado 80112
Oncology Hematology West Englewood Colorado 80112
SMO Catholic Health Initiatives Englewood Colorado 80112
St Joseph Cancer Center Englewood Colorado 80112
St. Francis Medical Center Englewood Colorado 80112
Medical Oncology Hematology Consultants Newark Delaware 19713
Boca Raton Regional Hospital Boca Raton Florida 33486
Halifax Medical Center Daytona Beach Florida 32114
Memorial Cancer Institute Pembroke Pines Florida 33028
H Lee Moffitt Cancer Center Tampa Florida 33612-9497
University Cancer & Blood Center, LLC Athens Georgia 30607
Ingalls Memorial Hospital Harvey Illinois 60426
Indiana University School of Medicine Indianapolis Indiana 46202
University of Iowa Iowa City Iowa 52242
Cancer Center of Kansas, P.A. Wichita Kansas 67214
Central Baptist Hospital Lexington Kentucky 40503
University of Louisville Louisville Kentucky 40202
Walter Reed National Military Medical Center Bethesda Maryland 20889
Metro-West and Greater Boston CNS Research Framingham Massachusetts 01701
Karmanos Cancer Institute Detroit Michigan 48201
Mercy Medical Research Institute Springfield Missouri 65807
Billings Clinic Research Center Billings Montana 59101
Dartmouth Hitchcock Medical Center Lebanon New Hampshire 03756
Broome Oncology Johnson City New York 13790
Weill Cornell Medical College New York New York 10065
Oncology Hematology Care Inc Cincinnati Ohio 45242
Oklahoma Cancer Specialists & Research Institute, LLC Tulsa Oklahoma 74146
Providence Cancer Center Oncology Hematology Care Portland Oregon 97213
UPMC Hillman Cancer Center Pittsburgh Pennsylvania 15213
Roper St. Francis Healthcare Charleston South Carolina 29401
Chattanooga Oncology Hematology Associates Chattanooga Tennessee 37404
Chattanooga Oncology Hematology Associates Nashville Tennessee 37203
Tennessee Oncology PLLC Nashville Tennessee 37203
Mary Crowley Cancer Research Center Dallas Texas 75230
Utah Cancer Specialists Salt Lake City Utah 84106
University of Vermont Medical Center Burlington Vermont 05401
Virginia Commonwealth University Richmond Virginia 23298
Kadlec Clinical Hematology & Oncology Kennewick Washington 99336
Swedish Medical Center Seattle Washington 98104
Cancer Care Northwest Valley Washington 99216

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 177 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02152631, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Feb 5, 2026 · Synced Apr 23, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT02152631 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →